When was Nobles Medical Technology founded?

Nobles Medical Technology was founded in 2009 and raised its 1st funding round 3 years after it was founded.

Where is Nobles Medical Technology located?

Nobles Medical Technology is headquartered in Fountain Valley, United States.

Who is the current CEO of Nobles Medical Technology?

Anthony Nobles of Nobles Medical Technology.

How many employees does Nobles Medical Technology have?

As of May 31, 2026, the latest employee count at Nobles Medical Technology is 1.

Is Nobles Medical Technology a funded company?

Nobles Medical Technology is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Oct 29, 2012.

When was the latest funding round of Nobles Medical Technology?

Nobles Medical Technology's latest funding was a $***** Seed round on Oct 29, 2012, with participation from 0 investor.

Where does Nobles Medical Technology rank among its competitors?

Nobles Medical Technology ranks 14th amongst 13 active competitors, of which 7 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Xeltis, which secured $43.6M in Dec, 2025.

Who are the top competitors of Nobles Medical Technology?

Nobles Medical Technology's top competitors include Xeltis, Occlutech and PECA Labs. Among them, Xeltis secured the most recent funding round in December, 2025.

Nobles Medical Technology - 2026 Company Profile, Team, Funding & Competitors

Company Details

Nobles Medical Technologies II develops suture-based patent foramen ovale closure systems. It offers SuperStitch, a line of vascular suturing products that enables physicians to close the puncture or incision site directly. The company also provides NobleStitch, which allows physicians to form an “S” shaped suture foreclosure of the PFO tunnel, and to tie sutures together using the KwiKnot with an integrated suture cutter. Its third product KwiKnot is an accessory to the NobleStitch to advance a “knot” to the suturing site, as well as cut it. Performed a live closure at Congress for CSI, a gathering for cardiologists and physicians in Dec 2015.

Website: noblesmedicaltechnology.com
Part Of

Key Metrics

Founded Year

2009

Location

Fountain Valley, United States

Stage

Seed

Total Funding

$399K in 1 round

Latest Funding Round

Seed, Oct 29, 2012, $*****

Ranked

14^th among 16 competitors

Employee Count

1 as on May 31, 2026

Similar Companies

Xeltis & 14 more

View Nobles Medical Technology's full profile

Nobles Medical Technology has raised a total funding of $399K over 1 round.

Here is the list of recent funding rounds of Nobles Medical Technology:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 29, 2012	7886951	Seed	2044795	6929546	4292501	2725321

Access funding benchmarks and valuations. Sign up today!

View details of Nobles Medical Technology's funding rounds and investors

The founders of Nobles Medical Technology is Anthony Nobles.

Here are the details of Nobles Medical Technology's key team members:

Anthony Nobles: Chairman and CEO, Founder of Nobles Medical Technology.

View details of Nobles Medical Technology's Founder profiles and Board Members

Nobles Medical Technology's employee count trend

Nobles Medical Technology has 1 employees as of May 26. Here is Nobles Medical Technology's employee count trend over the years:

Employee count trend for Nobles Medical Technology

Uncover Nobles Medical Technology's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nobles Medical Technology include Xeltis, Occlutech and PECA Labs. Here is the list of Top 10 competitors of Nobles Medical Technology, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Xeltis 2006, Zurich (Switzerland), Series D	Developer of bioabsorbable synthetic heart valves and vascular grafts	$176M	Life Sciences Partners, Kurma Partners & 13 others	59/100
2nd	Occlutech 2003, Schaffhausen (Switzerland), Series C	Provider of minimally invasive cardiac devices for congenital heart defects, stroke prevention and heart failure	$70.8M	Fjarde AP-fonden, Carnegie & 5 others	56/100
3rd	PECA Labs 2011, Pittsburgh (United States), Series B	Developer of pediatric cardiac surgical devices	$22.6M	BlueTree Allied Angels, Innovation Works & 4 others	47/100
4th	Endonovo Therapeutics 2011, Los Angeles (United States), Public	Bioelectronic devices and therapies for regenerative medicine	-	Kodiak Capital, Azure Capital Partners & 2 others	44/100
5th	Cierra 2003, Redwood City (United States), Series A	A device for the treatment of patent foramen ovale	$21M	Delphi Ventures, The Foundry & 3 others	36/100
6th	Cardia 1998, Eagan (United States), Early Stage	Products for transvenous closures of certain types of congenital heart defects.	$5.64M	-	35/100
7th	AdvancedCPR Solutions 2015, Edina (United States), Series A	Improving CPR outcomes through innovative patient positioning solutions and training	$9.51M	HHS	33/100
8th	Coherex 2003, Salt Lake City (United States), Acqui-Hired	Implant for structural heart disease conditions	$25M	Saints Capital, Tullis Health Investors & 3 others	31/100
9th	AGA Medical 1995, Plymouth (United States), Acquired	Cardiac rhythm management solutions improving patient care through innovative technology	-	Welsh, Carson, Anderson & Stowe	25/100
10th	atHeart Medical 2020, Baar (Switzerland), Unfunded	Developer of an occluder for a cardiac disorder	-	-	22/100
14th	Nobles Medical Technology 2009, Fountain Valley (United States), Seed	Vascular suturing products for PFO closure	$399K	-	16/100